Abstract:Klebsiella pneumoniae is a promising industrial microorganism as well as a major human pathogen. The recent emergence of carbapenem-resistant K. pneumoniae has posed a serious threat to public health worldwide, emphasizing a dire need for novel therapeutic means against drug-resistant K. pneumoniae Despite the critical importance of genetics in bioengineering, physiology studies, and therapeutic-means development, genome editing, in particular, the highly desirable scarless genetic manipulation in K. pneumoniae, is often time-consuming and laborious. Here, we report a two-plasmid system, pCasKP-pSGKP, used for precise and iterative genome editing in K. pneumoniae By harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 genome cleavage system and the lambda Red recombination system, pCasKP-pSGKP enabled highly efficient genome editing in K. pneumoniae using a short repair template. Moreover, we developed a cytidine base-editing system, pBECKP, for precise C→T conversion in both the chromosomal and plasmid-borne genes by engineering the fusion of the cytidine deaminase APOBEC1 and a Cas9 nickase. By using both the pCasKP-pSGKP and the pBECKP tools, the blaKPC-2 gene was confirmed to be the major factor that contributed to the carbapenem resistance of a hypermucoviscous carbapenem-resistant K. pneumoniae strain. The development of the two editing tools will significantly facilitate the genetic engineering of K. pneumoniaeIMPORTANCE Genetics is a key means to study bacterial physiology. However, the highly desirable scarless genetic manipulation is often time-consuming and laborious for the major human pathogen K. pneumoniae We developed a CRISPR-Cas9-mediated genome-editing method and a cytidine base-editing system, enabling rapid, highly efficient, and iterative genome editing in both industrial and clinically isolated K. pneumoniae strains. We applied both tools in dissecting the drug resistance mechanism of a hypermucoviscous carbapenem-resistant K. pneumoniae strain, elucidating that the blaKPC-2 gene was the major factor that contributed to the carbapenem resistance of the hypermucoviscous carbapenem-resistant K. pneumoniae strain. Utilization of the two tools will dramatically accelerate a wide variety of investigations in diverse K. pneumoniae strains and relevant Enterobacteriaceae species, such as gene characterization, drug discovery, and metabolic engineering.

Highly Efficient Base Editing in Staphylococcus Aureus Using an Engineered CRISPR RNA-guided Cytidine Deaminase.

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Highly Efficient Base Editing in Bacteria Using a Cas9-cytidine Deaminase Fusion

Base editing in Streptomyces with Cas9 deaminase fusions

CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus.

Identification of Editable Sites, Spacer Oligonucleotide Design, and Generation of the Gene-Targeting CRISPR-nCas9 Plasmid for Gene Disruption in Staphylococcus aureus Using the CRISPR-nCas9 and Cytidine Deaminase System

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Developing a CRISPR-assisted base-editing system for genome engineering of Pseudomonas chlororaphis

Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria

Expanding targeting scope, editing window, and base transition capability of base editing in Corynebacterium glutamicum.

CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440

CRISPR/Cas9-deaminase Enables Robust Base Editing in Rhodobacter Sphaeroides 2.4.1

CRISPR/Cpf1-Mediated Multiplex and Large-Fragment Gene Editing in Staphylococcus aureus

Multiplex Genome Editing Using a Dcas9-Cytidine Deaminase Fusion in Streptomyces

Efficient DNA base editing via an optimized DYW-like deaminase

Engineered DNase-inactive Cpf1 Variants to Improve Targeting Scope for Base Editing in E. Coli

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella Pneumoniae

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

In vivo genome editing using Staphylococcus aureus Cas9

Deaminase-mediated multiplex genome editing in Escherichia coli